Cite
BLT-Immune Humanized Mice as a Model for Nivolumab-Induced Immune-Mediated Adverse Events: Comparison of the NOG and NOG-EXL Strains.
MLA
Weaver, James L., et al. “BLT-Immune Humanized Mice as a Model for Nivolumab-Induced Immune-Mediated Adverse Events: Comparison of the NOG and NOG-EXL Strains.” Toxicological Sciences, vol. 169, no. 1, May 2019, pp. 194–208. EBSCOhost, https://doi.org/10.1093/toxsci/kfz045.
APA
Weaver, J. L., Zadrozny, L. M., Gabrielson, K., Semple, K. M., Shea, K. I., & Howard, K. E. (2019). BLT-Immune Humanized Mice as a Model for Nivolumab-Induced Immune-Mediated Adverse Events: Comparison of the NOG and NOG-EXL Strains. Toxicological Sciences, 169(1), 194–208. https://doi.org/10.1093/toxsci/kfz045
Chicago
Weaver, James L, Leah M Zadrozny, Kathleen Gabrielson, Kenrick M Semple, Katherine I Shea, and Kristina E Howard. 2019. “BLT-Immune Humanized Mice as a Model for Nivolumab-Induced Immune-Mediated Adverse Events: Comparison of the NOG and NOG-EXL Strains.” Toxicological Sciences 169 (1): 194–208. doi:10.1093/toxsci/kfz045.